• SENSEX 77,414.92
    -191.51 (--0.25%)
  • BANKNIFTY 51,564.85
    -11.00 (--0.02%)
  • Hind.Aeronautics
    4,294.00 5,675.00(%)
  • Zomato Ltd
    200.50 146.85(%)
  • Aster DM Health.
    504.00 558.30(%)
  • Reliance Industr
    1,269.05 1,156.00(%)
  • Tata Motors
    684.90 1,179.05(%)
  • Jio Financial
    232.25 394.70(%)
  • Mazagon Dock
    2,635.55 920.48(%)
  • Vodafone Idea
    6.77 6.60(%)
  • HDFC Bank
    1,836.40 1,880.00(%)
  • Suzlon Energy
    56.40 37.95(%)
  • M & M
    2,635.10 1,872.45(%)
  • IDFC First Bank
    54.63 52.60(%)
  • Dixon Technolog.
    13,019.00 7,100.05(%)
  • I R F C
    123.65 108.05(%)
  • Bharat Electron
    306.50 340.35(%)
  • Adani Energy Sol
    863.60 588.25(%)
  • Asian Paints
    2,322.35 2,125.00(%)
  • Reliance Power
    44.75 54.25(%)
  • Hindustan Copper
    218.75 195.35(%)
  • IndusInd Bank
    643.70 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Jagsonpal Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 2171.0
  • ISIN : INE048B01035
217.20 -5 (-2.38%)
  • As on 31 Mar 2025 (EOD)

  • Today’s Low

    215.05

  • Today’s High

    225.10

  • Open

    223.00

  • Perv Close

    222.50

  • 52W Low

    109.48

  • 52W High

    328.04

Key Indicators

  • P/E(TTM)

    39.34

  • Mar.Cap (₹Cr.)

    1,441.93

  • Div & Yield %

    0.92

  • Book Value(₹)

    29.70

  • Debt-Equity Ratio

    -2.38

  • AGM Date

    28-Mar-2025

  • EPS

    5.49

  • P/E Ratio

    39.34

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    1,441.93

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    13.28

  • BV (₹)

    29.70

  • Sales( ₹ in Cr.)

    208.70

  • NP (in Cr.)

    22.46

  • NP Var(%)

    -21.0

  • Div%

    100.0

  • CPS (₹)

    3.60

  • EPS (₹)

    3.40

  • Traded Value (₹ in Lakhs)

    1,433.63

  • 52 Week High

    328.04

  • 52 Week Low

    109.48

  • Price BSE

    216.0

  • Price NSE

    217.00

  • Market Capital( in Cr.)

    1,433.63

  • P/C Ratio

    59.40

  • P/E Ratio

    63.80

  • Price Vs.BV

    3.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 208.70 236.71 217.58 187.95 158.57 166.83
Excise Duty 208.70 236.71 217.58 187.88 158.57 166.83
Net Sales 208.70 236.71 217.58 187.95 158.57 166.83
Other Income 9.28 5.73 3.43 4.39 2.53 1.43
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 217.98 242.45 221.01 192.34 161.09 168.25
EXPENDITURE :
Raw Materials 208.70 236.71 217.58 187.88 158.57 166.83
Power & Fuel Cost 208.70 236.71 217.58 187.88 158.57 166.83
Employee Cost 61.80 65.18 57.68 53.98 50.37 46.61
Other Manufacturing Expenses 1.87 2.57 2.05 1.22 4.04 3.66
Selling & Administrative Expenses 41.66 42.01 43.23 31.88 38.34 32.23
Miscellaneous Expenses 1.87 2.57 2.05 1.22 4.04 3.66
Less : Pre-operative Expenses Capitalised :
Total Expenditure 188.11 204.18 194.37 170.47 151.68 159.25
Operating Profit 0.33 0.46 0.65 1.00 1.09 2.14
Interest 0.81 0.41 0.29 0.51 0.51 0.75
Gross Profit 29.87 34.81 26.64 21.87 9.41 9.00
Depreciation 1.66 1.21 1.53 1.09 1.13 1.02
Profit Before Tax 29.87 34.81 26.64 21.87 9.41 9.00
Tax 7.56 8.14 7.40 6.05 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.15 0.46 0.38 -1.23 -0.03 -0.07
Reported Net Profit 22.46 26.72 18.86 17.06 7.87 7.22
Extraordinary Items 29.87 34.81 26.64 21.87 9.41 9.00
Adjusted Net Profit 22.46 26.72 18.86 17.06 7.87 7.22
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 13.22 13.10 10.48 2.62 1.31 0.65
P & L Balance carried down 22.46 26.72 18.86 17.06 7.87 7.22
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 100.00 100.00 80.00 20.00 10.00 5.00
Dividend Per Share(Rs) 5.00 5.00 4.00 1.00 0.50 0.25
Earnings Per Share-Unit Curr 8.49 10.20 7.20 6.51 3.00 2.75
Book Value 13.22 13.10 10.48 2.62 1.31 0.65
Book Value(Adj)-Unit Curr 13.22 13.10 10.48 2.62 1.31 0.65

Shareholding Pattern

  • Promoter Group

    67.81%

  • Public Share Holding

    32.19%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 9,168,320 34.54 9,168,320 2
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 2,287,180 2,287,180.00 2,287,180 2,287,180
Sub Total 11,455,500 43.15 11,455,500 3
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 5,334,254 20.09 5,334,254 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,212,160 4.57 1,212,160 1
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 6,546,414 24.66 6,546,414 2
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 800 0.00 600 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 557,432 2.10 557,432 14
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 558,232 2.10 558,032 16
2] Non Institution
Bodies Corporate 790,962 2.98 790,082 122
Clearing Members 21,559 0.08 21,559 27
Directors of their Relatives 103,074 0.39 103,074 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 150,395 0.57 150,395 237
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 294,065 1.11 294,065 312
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,481,659 5.58 1,481,659 7
Individuals holding nominal share capital up to Rs. 1 lakh 3,996,822 15.06 3,805,127 17,740
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 2,000 0.01 2,000 1
Others 1,145,280 4.31 1,145,280 3
Sub Total 7,985,816 30.08 7,793,241 18,450
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 26,545,962 100.00 26,353,187 18,471

Company Background

Jagsonpal Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Jagsonpal Pharmaceuticals Ltd
  • BSE Code : 2171.0
  • ISIN : INE048B01035

  • Incorporation Year

    1978

  • Registered Office

    T-210 J
    Shahpur Jat, New Delhi,
    New Delhi-110049

  • Telephone

    91-011-46181100/46109900

  • FAX

    91-011-26498341

  • Chairman

    Harsha Raghavan

  • Managing Director

    Manish Gupta

  • Company Secretary

  • Auditor

    Walker Chandiok & Co LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MCS Ltd
    F-65 1st Floor,
    Okhla Industrial Are,Phase-I
    Mumbai - New Delhi-110020

Jagsonpal Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Jagsonpal Pharma 215.95 217.98 208.70 27.40 16.89
Abbott India 30,730.65 6,097.18 5,848.91 48.94 44.71
Astrazeneca Phar 8,606.35 1,330.33 1,295.53 221.87 33.26
P & G Health Ltd 5,142.30 1,166.89 1,151.26 36.08 39.76
Glaxosmi. Pharma 2,877.30 3,530.73 3,407.25 57.21 44.44
Cipla 1,441.70 17,645.00 16,574.34 24.72 20.10
Amrutanjan Healt 644.85 437.58 421.23 37.80 20.84
Guj. Themis Bio. 281.50 174.19 169.82 58.28 44.82
Fermenta Biotec. 273.55 315.24 307.09 25.93 4.10
Bliss GVS Pharma 117.55 638.96 605.46 26.90 11.19
Ambalal Sarabhai 35.05 11.70 3.81 14.98 1.92